MENU
ITRM
AS OF
Dec 12 closing price
Price
$0.45
Change
-$0.02 (-4.26%)
Capitalization
23.75M
89 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ITRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Iterum Therapeutics (ITRM) Ownership - Who owns Iterum Therapeutics?

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.75M
P/E Ratio
N/A
Total Cash
11M
Projected Growth
N/A
Total Debt
33.74M
Revenue
390K
Risk (Beta)
5.17
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price

Fundamentals

ITRM
Capitalization
23.8M
P/E Ratio
N/A
Risk (Beta)
5.17
Dividend Yield
N/A
Total Cash
11M
Total Cash/Share
0.21
Total Debt
33.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
390K
ROE
N/A
Book Value
-7.38M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.72
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
490K
Current Ratio
2.13
Current Revenue Per Employee
43333.33
Dividends Per Share - Security
N/A
EBITDA
-23.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
94.87
Revenue To Assets
-111.35
Shares Held By Institutions
768K
Shares Outstanding - Current
52.8M
Total Liabilities
39.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-73.480
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ITRM
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ITRM showed earnings on November 14, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ITRM
A.I. Advisor
published General Information

General Information

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com